Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 3 studies | 43% ± 10% |
Insufficient scRNA-seq data for expression of HPR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 17857.33 | 226 / 226 | 92% | 390.47 | 372 / 406 |
brain | 87% | 293.68 | 2295 / 2642 | 87% | 18.71 | 611 / 705 |
heart | 98% | 2130.15 | 844 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 62% | 364.02 | 822 / 1335 | 0% | 0 | 0 / 0 |
ovary | 56% | 80.26 | 101 / 180 | 3% | 0.13 | 12 / 430 |
adipose | 50% | 177.37 | 601 / 1204 | 0% | 0 | 0 / 0 |
kidney | 33% | 117.17 | 29 / 89 | 5% | 1.61 | 45 / 901 |
lung | 28% | 64.60 | 161 / 578 | 4% | 0.28 | 42 / 1155 |
esophagus | 24% | 43.56 | 348 / 1445 | 2% | 0.06 | 3 / 183 |
breast | 23% | 80.17 | 104 / 459 | 1% | 0.13 | 15 / 1118 |
prostate | 20% | 64.65 | 49 / 245 | 3% | 0.24 | 15 / 502 |
stomach | 19% | 48.29 | 67 / 359 | 0% | 0.01 | 1 / 286 |
intestine | 15% | 34.96 | 141 / 966 | 2% | 0.51 | 10 / 527 |
uterus | 12% | 34.22 | 21 / 170 | 2% | 0.09 | 8 / 459 |
muscle | 14% | 28.86 | 113 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 12% | 23.44 | 112 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 3% | 9.41 | 9 / 258 | 5% | 0.32 | 12 / 230 |
thymus | 8% | 53.16 | 51 / 653 | 1% | 0.03 | 4 / 605 |
bladder | 5% | 2.76 | 1 / 21 | 2% | 0.10 | 9 / 504 |
skin | 6% | 16.48 | 103 / 1809 | 1% | 0.06 | 4 / 472 |
pancreas | 2% | 7.87 | 8 / 328 | 3% | 0.55 | 5 / 178 |
spleen | 3% | 23.51 | 7 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005615 | Cellular component | extracellular space |
GO_0072562 | Cellular component | blood microparticle |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0034366 | Cellular component | spherical high-density lipoprotein particle |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
GO_0030492 | Molecular function | hemoglobin binding |
Gene name | HPR |
Protein name | Haptoglobin-related protein |
Synonyms | |
Description | FUNCTION: Primate-specific plasma protein associated with apolipoprotein L-I (apoL-I)-containing high-density lipoprotein (HDL). This HDL particle, termed trypanosome lytic factor-1 (TLF-1), mediates human innate immune protection against many species of African trypanosomes. Binds hemoglobin with high affinity and may contribute to the clearance of cell-free hemoglobin to allow hepatic recycling of heme iron. . |
Accessions | ENST00000540303.7 [P00739-1] ENST00000561690.1 A0A3B3ISM1 P00739 ENST00000649683.1 J3KTC3 |